| Financial Year |
March 31 2023 |
| Monetary Funds |
816,791,853.86 |
| Held-for-trading Financial Assets |
10,127,119.26 |
| Notes Receivable |
1,265,074,288.87 |
| Accounts Receivable |
1,159,139,745.23 |
| Advances to Suppliers |
116,189,296.76 |
| Other Receivables |
872,492.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
425,660,464.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,860,504.48 |
| Total Current Assets |
3,806,715,766.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
19,848,585.63 |
| Fixed Assetes |
92,488,599.54 |
| Under-construction Projects |
110,244,982.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
17,612,376.01 |
| R&D expenses |
-- |
| Goodwill |
33,232,209.72 |
| Long-Term Deferred and Prepaid Expenses |
240,454.35 |
| Deferred Income Tax Assets |
24,931,668.72 |
| Other Non-Current Assets |
24,775,853.51 |
| Sub-Total of Non-Current Assets |
362,455,359.32 |
| Total Assets |
4,169,171,125.70 |
| Short-Term Loans |
1,960,198,734.83 |
| Trading Financial liabilities |
43,603,359.63 |
| Notes Payable |
817,677,855.05 |
| Accounts Payable |
229,014,947.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,414,597.41 |
| Taxes Payable |
45,765,392.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,299,122.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,233,025.75 |
| Other Current Liabilities |
808,653.49 |
| Sub-Total of Current Liabilities |
3,115,236,099.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,542,716.99 |
| Deferred Income Tax Liabilities |
559,759.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
23,287,617.81 |
| Total Liabilities |
3,138,523,717.62 |
| Paid-In Capital(Or Share Stock) |
100,000,000.00 |
| Capital Surplus |
530,354,016.62 |
| Surplus Reserve |
31,267,122.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
344,582,365.21 |
| Minority Stockholder's Interest |
24,901,237.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,005,746,170.69 |
| Owner's Equity（Stockholder's Equity） |
1,030,647,408.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,169,171,125.70 |
